Faizan Khan, PhD
@FaizanK91
Followers
1K
Following
2K
Statuses
832
#BantingCanada Postdoctoral Fellow @uCalgaryMed @HotchkissBrain | Associate Editor @JTHjournal |
Calgary, Alberta
Joined June 2011
🆕Hot off the press! Read our @TheLancet Seminar (Ch.1 of my PhD) for a comprehensive overview of #VTE. We summarize the latest evidence + provide guidance for clinicians on epidemiology, pathophysiology, diagnosis, treatment & prevention of #DVT and #PE.
6
101
334
RT @MarcCarrier1: @ASH_hematology Late Breaking Abstract: Should patients receive extended duration anticoagulation with reduced or full do…
0
27
0
@MarcCarrier1 @ASH_hematology @FCouturaud @INNOVTE1 @INVENT_VTE @canvector @isth @thrombosisday @ThrombosisCan Congrats @FCouturaud et al. 🎉 Looking forward to the full publication!
0
0
4
@MarcCarrier1 @uOttawa @JRand083 @DebSiegal @RoyKhalifeMD @PhilWellsMD1 @OttawaHospital @uOttawaMed @OttMethodsCentr Congrats Deb and Joe! #OttawaProud 💪
0
0
2
🆕 publication from my #BantingCanada fellowship out today in @JAMANeuro highlights the significant gender disparities in case-fatality rate of stroke - a measure of stroke burden that hasn’t improved much over time.🧠
0
3
10
🚨🆕 My latest publication in @JACCJournals w/ @MarcCarrier1 & @Bram_Rochwerg uses the case of anticoagulants for cancer-associated #VTE to stress the importance of GRADEing the certainty of evidence when interpreting findings from a network meta-analysis.
0
10
27
Sad to have missed #ICTHIC2024 this year. Thanks @MarcCarrier1 for presenting our meta-analysis of prognostic factors associated w/ recurrent #VTE in patients with cancer-associated VTE. Stay tuned for the full publication, including factors for bleeding in these patients.
A grant finale of #ICTHIC2024 🎆Systematic review and meta-analysis by Dr. @MarcCarrier1 et. al identified multiple risk factors for recurrent VTE in patients with cancer-associated thrombosis.
0
7
23
RT @SLaframboise14: #GradStudent scholarships and #Postdoc fellowships got a raise today for the first time in 21 years🙌 Immensely gratefu…
0
103
0
📣🆕 Check out the latest publication from my #BantingCanada fellowship out today in @yourICM! We highlight key factors that increase #VTE/bleeding risk in critically ill patients & should be considered to tailor thromboprophylaxis in the ICU.
0
7
24
Our 🆕 letter in @JAMAInternalMed discusses the limitations/biases in retrospective data on safety of thrombolytics in patients taking #DOACs. We are in dire need of prospective/randomized evidence to inform treatment decisions in this clinical setting🧠
1
7
16
0
0
0
0
0
1
@TotoMynell @DOIT_trial @DavidSeiffge @FishingNeurons Dr. Meinel - aside from the X account, do you have a website or registration number of the DO-IT prospective registry that one could cite.
1
0
0